CDKL5 is a brain MeCP2 target gene regulated by DNA methylation

[1]  J. Zwiller,et al.  Cocaine self-administration alters the expression of chromatin-remodelling proteins; modulation by histone deacetylase inhibition , 2011, Journal of psychopharmacology.

[2]  M. Cilio,et al.  Early-onset seizure variant of Rett syndrome: Definition of the clinical diagnostic criteria , 2010, Brain & development (Tokyo. 1979).

[3]  S. Ricciardi,et al.  CDKL5 influences RNA splicing activity by its association to the nuclear speckle molecular machinery. , 2009, Human molecular genetics.

[4]  James P. Curley,et al.  Epigenetic mechanisms mediating the long-term effects of maternal care on development , 2009, Neuroscience & Biobehavioral Reviews.

[5]  R. Jaenisch,et al.  Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function , 2009, Proceedings of the National Academy of Sciences.

[6]  Gustavo Turecki,et al.  Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse , 2009, Nature Neuroscience.

[7]  V. Saletti,et al.  Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes , 2009, neurogenetics.

[8]  H. Nagase,et al.  Tissue specific differentially methylated regions (TDMR): Changes in DNA methylation during development. , 2009, Genomics.

[9]  I. Suetake,et al.  Cyclin-dependent kinase-like 5 binds and phosphorylates DNA methyltransferase 1. , 2008, Biochemical and biophysical research communications.

[10]  N. Landsberger,et al.  CDKL5 Expression Is Modulated during Neuronal Development and Its Subcellular Distribution Is Tightly Regulated by the C-terminal Tail* , 2008, Journal of Biological Chemistry.

[11]  N. Boddaert,et al.  Key clinical features to identify girls with CDKL5 mutations. , 2008, Brain : a journal of neurology.

[12]  J. Zwiller,et al.  Histone Deacetylase Inhibitors Decrease Cocaine But Not Sucrose Self-Administration in Rats , 2008, The Journal of Neuroscience.

[13]  T. Bestor,et al.  The Colorful History of Active DNA Demethylation , 2008, Cell.

[14]  M. Greenberg,et al.  Activating a Repressor , 2008, Science.

[15]  V. Beneš,et al.  Cyclical DNA methylation of a transcriptionally active promoter , 2008, Nature.

[16]  Jim Stalker,et al.  A Novel CpG Island Set Identifies Tissue-Specific Methylation at Developmental Gene Loci , 2008, PLoS biology.

[17]  Huda Y. Zoghbi,et al.  The Story of Rett Syndrome: From Clinic to Neurobiology , 2007, Neuron.

[18]  Peter A. Jones,et al.  DNA methylation: The nuts and bolts of repression , 2007, Journal of cellular physiology.

[19]  Christian Rosenmund,et al.  MeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse Number , 2007, Neuron.

[20]  R. Duman,et al.  Epigenetic Marking and Neuronal Plasticity , 2007, Biological Psychiatry.

[21]  G. Ratto,et al.  Spatio-temporal Dynamics and Localization of MeCP2 and Pathological Mutants in Living Cells , 2007, Epigenetics.

[22]  A. Feinberg.  Phenotypic plasticity and the epigenetics of human disease , 2007, Nature.

[23]  Eric J. Nestler,et al.  Epigenetic regulation in psychiatric disorders , 2007, Nature Reviews Neuroscience.

[24]  I. Sora,et al.  Methamphetamine alters expression of DNA methyltransferase 1 mRNA in rat brain , 2007, Neuroscience Letters.

[25]  Christoph Plass,et al.  Toward a human epigenome , 2006, Nature Genetics.

[26]  Christina Thaller,et al.  Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome , 2006, Proceedings of the National Academy of Sciences.

[27]  J. Rogers,et al.  DNA methylation profiling of human chromosomes 6, 20 and 22 , 2006, Nature Genetics.

[28]  G. Forlani,et al.  Functional Consequences of Mutations in CDKL5, an X-linked Gene Involved in Infantile Spasms and Mental Retardation* , 2006, Journal of Biological Chemistry.

[29]  Eric C. Griffith,et al.  Brain-Specific Phosphorylation of MeCP2 Regulates Activity-Dependent Bdnf Transcription, Dendritic Growth, and Spine Maturation , 2006, Neuron.

[30]  S. Akbarian,et al.  Chromatin immunoprecipitation in postmortem brain , 2006, Journal of Neuroscience Methods.

[31]  J. Zwiller,et al.  Fluoxetine and Cocaine Induce the Epigenetic Factors MeCP2 and MBD1 in Adult Rat Brain , 2006, Molecular Pharmacology.

[32]  R. Duman,et al.  Chromatin Remodeling: A Novel Mechanism of Psychotropic Drug Action , 2006, Molecular Pharmacology.

[33]  J. LaSalle,et al.  Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. , 2006, Human molecular genetics.

[34]  I. Weaver,et al.  Maternal Care Associated with Methylation of the Estrogen Receptor-α1b Promoter and Estrogen Receptor-α Expression in the Medial Preoptic Area of Female Offspring , 2006 .

[35]  P. Tam,et al.  Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. , 2006, Brain : a journal of neurology.

[36]  A. Bird,et al.  Genomic DNA methylation: the mark and its mediators. , 2006, Trends in biochemical sciences.

[37]  M. Rosner,et al.  CDKL5/Stk9 kinase inactivation is associated with neuronal developmental disorders. , 2005, Human molecular genetics.

[38]  A. Bird,et al.  DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. , 2005, Molecular cell.

[39]  J. Gécz,et al.  Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. , 2005, American journal of human genetics.

[40]  N. Landsberger,et al.  CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. , 2005, Human molecular genetics.

[41]  W. Lam,et al.  Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells , 2005, Nature Genetics.

[42]  A. Renieri,et al.  CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms , 2005, Journal of Medical Genetics.

[43]  J. Gécz,et al.  Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. , 2004, American journal of human genetics.

[44]  J. Gécz,et al.  Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. , 2004, American journal of human genetics.

[45]  J. Zwiller,et al.  Activation of the cGMP Pathway in Dopaminergic Structures Reduces Cocaine-Induced EGR-1 Expression and Locomotor Activity , 2004, The Journal of Neuroscience.

[46]  Mark Groudine,et al.  Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells , 2004, Nature Structural &Molecular Biology.

[47]  Peter A. Jones,et al.  Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.

[48]  J. Zwiller,et al.  Expression of the methyl-CpG-binding protein MeCP2 in rat brain. An ontogenetic study , 2004, Neurobiology of Disease.

[49]  R. Jaenisch,et al.  Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[50]  E. Li.  Chromatin modification and epigenetic reprogramming in mammalian development , 2002, Nature Reviews Genetics.

[51]  Daiya Takai,et al.  Comprehensive analysis of CpG islands in human chromosomes 21 and 22 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[52]  A. Bird.  Methylation Talk Between Histones and DNA , 2001, Science.

[53]  R. Jaenisch,et al.  Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice , 2001, Nature Genetics.

[54]  P. Basset,et al.  Multiple Regulatory Elements in the Murine Stromelysin-3 Promoter , 2000, The Journal of Biological Chemistry.

[55]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[56]  A. Razin,et al.  CpG methylation, chromatin structure and gene silencing—a three‐way connection , 1998, The EMBO journal.

[57]  J. Strouboulis,et al.  Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription , 1998, Nature Genetics.

[58]  Colin A. Johnson,et al.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.

[59]  A. Bird,et al.  MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin , 1997, Cell.

[60]  D. Clegg,et al.  Efficient transfection and expression of heterologous genes in PC12 cells. , 1990, DNA and cell biology.

[61]  M. Frommer,et al.  CpG islands in vertebrate genomes. , 1987, Journal of molecular biology.

[62]  A. Bird.  DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[63]  J. Herman,et al.  Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer , 1999, Nature Genetics.